A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
type: MedicalStudy
description: An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2007-03
end date: 2011-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00451958
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Ferring Pharmaceuticals
study subject: Prostate Cancer
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Prostate Cancer

AI Analytics
type: Organization